Advanced search
Publication Cover
HIV Clinical Trials Volume 4, 2003 - Issue 4
Submit an article Journal homepage
40
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Combined Analysis of Two-Year Follow-Up from Two Open-Label Randomized Trials Comparing Efficacy of Three Nucleoside Reverse Transcriptase Inhibitor Backbones for Previously Untreated HIV-1 Infection: OzCombo 1 and 2

J AminNational Centre in HIV Epidemiology and Clinical ResearchUniversity of New South Wales, Sydney, NSW, AustraliaCorrespondence[email protected]
,
A. MooreNational Centre in HIV Epidemiology and Clinical ResearchUniversity of New South Wales, Sydney, NSW, Australia
,
A CarrHIV Immunology and Infectious Disease Clinical Services Unit, St Vincent's Hospital, Sydney, Australia
,
M.A. FrenchDepartment of Clinical Immunology and Communicable Diseases ServicesRoyal Perth Hospital, Perth, Australia
,
M LawNational Centre in HIV Epidemiology and Clinical ResearchUniversity of New South Wales, Sydney, NSW, Australia
,
S EmeryNational Centre in HIV Epidemiology and Clinical ResearchUniversity of New South Wales, Sydney, NSW, Australia
&
D.A CooperNational Centre in HIV Epidemiology and Clinical ResearchUniversity of New South Wales, Sydney, NSW, Australia;HIV Immunology and Infectious Disease Clinical Services Unit, St Vincent's Hospital, Sydney, Australia
 show all
Pages 252-261 | Published online: 02 Feb 2015

REFERENCES

  • Yeni PG, Hammer SM, Carpenter CC, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recom-mendations of the International AIDS Society-USA Panel. JAMA. 2002;288:222–235.
  • Draft 2001. Australian antiretroviral guidelines. 2001. Internet Communication. http://www.ashm.org.au/uploadFile/GUIDELINES2.pdf
  • Carr A, Chuah J, Hudson J, et al. A randomized, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study. AIDS. 2000;14:1171–1180.
  • French M, Amin J, Roth N, et al. Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously un-treated HIV-1 infection: the OzCombo 2 study. HIV Clin Trials. 2002;3: 177–185.
  • Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;19(353):2093–2099.
  • Carr A, Miller J, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associ-ated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS. 2000;14:F25–F32.
  • Saint-Marc T, Partisani M, Poizot-Martin I, et al. A syn-drome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS. 1999;13:1659–1667.
  • Stata Statistical Software. College Station, TX: Stata Corp.; 2002.
  • d'Arminio Monforte A, Cozzi Lepri A, Rezza G, et al. In-sights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients. AIDS. 2000;14:499-507.
  • Dorrucci M, Pezzotti P, Grisorio B, et al. Time to discon-tinuation of the first highly active antiretroviral therapy regi-men: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens. AIDS. 200115:1733–1736.
  • Australian HIV Observational Database. Time trends in antiretroviral treatment use in Australia, 1997–2000. Ve-nereology. 200114: 162–168.
  • Mocroft A, Youle M, Moore A, et al. Reasons for modifica-tion and discontinuation of antiretrovirals: results from a single treatment centre. AIDS. 200115: 185–194.
  • Mellal SA, John M, Moore CB, James IR, McKinnon EJ. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS. 2000;14:1309–1316.
  • Mallon PWG, Miller J, Cooper DA, Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1 infected men starting therapy. AIDS. In press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.